I certainly wouldn't call it a criticism, just a s
Post# of 72440
(Total Views: 365)
Posted On: 03/31/2020 6:25:32 AM
I certainly wouldn't call it a criticism, just a slightly different take on possibilities. I believe we both view the potential for Brilacidin, and IPIX more broadly, the same way-excellent. And as you state-GLTA on this investment and health in general.
(0)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼